Implemeting ADCC assays in QC: When donor variability isn’t an option

Join us on November 29th 2017 where our expert scientists, Lisa Blackwood and Laura Munro, will co-host a webinar with DiscoverX to discuss single donor-derived KILR CD16 Effector Cells to ensure assay reproductibility for screening, characterization, and QC lot release antibody drugs. The webinar will focus on 2 qualification studies that were performed using these effectors to demonstrate More

Sartorius Stedim BioOutsource win Frost & Sullivan Customer Service Leadership Award in Bioanlaytical Contract Testing Services

Goettingen, GER | Glasgow, UK, October 24, 2017 – Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, received the prestigious Frost & Sullivan’s 2017 European Customer Service Leadership Award for Bioanalytical Contract Testing Services. Presented at the Frost & Sullivan ceremony yesterday evening in London, UK, this award recognizes the unique More

Alligator Bioscience Select Sartorius Stedim Cellca as Cell Line Development Partner

Following the news release from Alligator Bioscience on 12th June 2017, Sartorius Stedim Cellca GmbH is delighted to partner with the innovative Swedish biotech company, Alligator Bioscience to support the pre-clinical development of their 4-1BB immuno-oncology antibody ATOR-1017. ATOR-1017 is an agonistic antibody that activates the co-stimulatory receptor 4-1BB (also known as CD137) expressed on More

Cell Line Development Services

Download our slides to find out more about our cell line development services and the Cellca CHO Expression Platform.